FCN3 and ischemic stroke: Ficolin-2 and ficolin-3 occur at lower levels in ischemic stroke patients, due to their consumption in the acute phase of the pathology, and low ficolin-3 levels are associated with greater SAH severity (Füst et al., 2011; Orsini et al., 2014; Zanier et al., 2014).